多排CT引导下眶后低流量血管性病变内注射博来霉素硬化治疗的单中心经验
本研究回顾性纳入2010年1月至2021年9月在台湾某三级中心接受多排CT引导下病变内博来霉素注射硬化治疗的13例眶后低流量血管性病变患者,总体影像学缓解率为76.9%(13例中10例),静脉畸形组为75.0%(8例中6例),淋巴管畸形组为75.0%(4例中3例),3例(23.1%)出现轻微并发症,1例(7.7%)出现严重并发症,平均临床和影像随访8.3个月,未报告复发或进展。作者结论认为CT引导下病变内博来霉素注射硬化治疗是眶后低流量血管性病变有效且相对安全的微创治疗方法。
要点
- 总体影像学缓解率76.9%(13例中10例),静脉畸形组和淋巴管畸形组均为75.0%。
- 平均1.5次治疗,平均随访8.3个月,未报告复发或进展。
- 轻微并发症3例(23.1%),严重并发症1例(7.7%)。
核心结论
- CT引导下病变内博来霉素注射硬化治疗是眶后低流量血管性病变有效且相对安全的微创治疗方法,总体影像学缓解率为76.9%,平均1.5次治疗,并发症率低。
研究设计与样本
- 回顾性研究,纳入2010年1月至2021年9月在台湾某三级中心连续接受CT引导下病变内博来霉素注射硬化治疗的眶后低流量血管性病变患者13例(男7例、女6例,年龄范围1-57岁,平均年龄25.9岁),回顾性收集病历和影像资料。
关键影像表现/征象
- 病变类型包括淋巴管畸形4例、静脉淋巴管畸形1例、静脉畸形8例。
- 总体影像学缓解率为76.9%(13例中10例)。
诊断标准与关键数值
- 静脉畸形组影像学缓解率为75.0%(8例中6例)。
- 淋巴管畸形组影像学缓解率为75.0%(4例中3例)。
临床应用与阅片要点
- 作者结论认为CT引导下病变内博来霉素注射硬化治疗是眶后低流量血管性病变相对安全、有效且可行的替代治疗选择。
- 平均治疗1.5次,平均临床和影像随访8.3个月,未报告复发或进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study investigated the safety and efficacy of sclerotherapy with intralesional bleomycin injection (IBI) for retrobulbar orbital low-flow vascular lesions under multi-slice computed tomography (CT) guidance.
METHODS: Between January 2010 and September 2021, consecutive patients with retrobulbar orbital low-flow vascular lesions who underwent CT-guided IBI at a tertiary centre in Taiwan were enrolled. Their medical records and imaging data were retrospectively collected.
RESULTS: This study enrolled 13 patients (7 male and 6 female patients; age range: 1-57 years; mean age: 25.9 years) with lymphatic malformation (LM, n = 4), venolymphatic malformation (n = 1), and venous malformation (VM, n = 8). The overall radiological response rate was 76.9% (10 of 13); the radiological response rate was 75.0% in the VM group (6 of 8) and 75.0% in the LM group (3 of 4). Moreover, 3 patients (23.1%) had minor complications and 1 (7.7%) had a major complication. The mean clinical and radiological follow-up was 8.3 months and no recurrence or progression was reported.
CONCLUSION: CT-guided IBI is an effective and relatively safe minimally invasive treatment for retrobulbar orbital low-flow vascular lesions, with an overall radiological response rate of 76.9% in a mean of 1.5 sessions and a low complication rate.
ADVANCES IN KNOWLEDGE: CT-guided sclerotherapy with IBI is a relatively safe, effective, and feasible alternative treatment option for retrobulbar orbital low-flow vascular lesions.
引用
- Lin SN, Wu YM, Siow TY, et al. Sclerotherapy with intralesional bleomycin injection under guidance of multi-slice CT for retrobulbar orbital low-flow vascular lesions-single-center experience. Br J Radiol. 2024. PMID: 38263834. doi:10.1093/bjr/tqad008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。